RUNX family members are covalently modified and regulated by PIAS1-mediated sumoylation

J. H. Kim, J. W. Jang, Y. S. Lee, J. W. Lee, X. Z. Chi, Y. H. Li, M. K. Kim, D. M. Kim, B. S. Choi, J. Kim, H. M. Kim, A. Van Wijnen, Ily Park, S. C. Bae

Research output: Contribution to journalArticlepeer-review

15 Scopus citations


Transcription factors of the RUNX family (RUNXs), which play pivotal roles in normal development and neoplasia, are regulated by various post-translational modifications. To understand the molecular mechanisms underlying the regulation of RUNXs, we performed a large-scale functional genetic screen of a fly mutant library. The screen identified dPias (the fly ortholog of mammalian PIASs), an E3 ligase for the SUMO (small ubiquitin-like modifier) modification, as a novel genetic modifier of lz (the fly ortholog of mammalian RUNX3). Molecular biological analysis revealed that lz/RUNXs are sumoylated by dPias/PIAS1 at an evolutionarily conserved lysine residue (K372 of lz, K144 of RUNX1, K181 of RUNX2 and K148 of RUNX3). PIAS1-mediated sumoylation inhibited RUNX3 transactivation activity, and this modification was promoted by the AKT1 kinase. Importantly, PIAS1 failed to sumoylate some RUNX1 mutants associated with breast cancer. In nude mice, tumorigenicity was promoted by RUNX3 bearing a mutation in the sumoylation site, but suppressed by wild-type RUNX3. Our results suggest that RUNXs are sumoylated by PIAS1, and that this modification could play a critical role in the regulation of the tumor-suppressive activity of these proteins.

Original languageEnglish (US)
Article numbere101
Issue number4
StatePublished - Jan 1 2014


  • AKT1
  • PIAS1
  • RUNX3
  • sumoylation
  • tumor suppressor

ASJC Scopus subject areas

  • Molecular Biology
  • Cancer Research


Dive into the research topics of 'RUNX family members are covalently modified and regulated by PIAS1-mediated sumoylation'. Together they form a unique fingerprint.

Cite this